NF-κB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis

CY Wang, DC Guttridge, MW Mayo… - Molecular and cellular …, 1999 - Taylor & Francis
CY Wang, DC Guttridge, MW Mayo, AS Baldwin Jr
Molecular and cellular biology, 1999Taylor & Francis
Recent evidence indicates that the transcription factor NF-κB is a major effector of inducible
antiapoptotic mechanisms. For example, it was shown that NF-κB activation suppresses the
activation of caspase 8, the apical caspase in tumor necrosis factor (TNF) receptor family
signaling cascades, through the transcriptional regulation of certain TRAF and IAP proteins.
However, it was unknown whether NF-κB controls other key regulatory mechanisms in
apoptosis. Here we show that NF-κB activation suppresses mitochondrial release of …
Recent evidence indicates that the transcription factor NF-κB is a major effector of inducible antiapoptotic mechanisms. For example, it was shown that NF-κB activation suppresses the activation of caspase 8, the apical caspase in tumor necrosis factor (TNF) receptor family signaling cascades, through the transcriptional regulation of certain TRAF and IAP proteins. However, it was unknown whether NF-κB controls other key regulatory mechanisms in apoptosis. Here we show that NF-κB activation suppresses mitochondrial release of cytochrome cthrough the activation of the Bcl-2 family member A1/Bfl-1. The restoration of A1 in NF-κB null cells diminished TNF-induced apoptosis by reducing the release of proapoptotic cytochrome c from mitochondria. In addition, A1 potently inhibited etoposide-induced apoptosis by inhibiting the release of cytochrome c and by blocking caspase 3 activation. Our findings demonstrate that A1 is an important antiapoptotic gene controlled by NF-κB and establish that the prosurvival function of NF-κB can be manifested at multiple levels.
Taylor & Francis Online